HER2 Testing Guide Clarifies Rules, Process (CME/CE)

(MedPage Today) -- Oncologists should determine HER2 status for every invasive breast cancer, including recurrent disease and adhere to specific histologic criteria to define results, according to an updated clinical guideline.
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news